Supira Medical Overview
- Year Founded
-
2012
- Status
-
Private
- Employees
-
125
- Latest Deal Type
-
Series E
- Latest Deal Amount
-
$120M
- Investors
-
10
Supira Medical General Information
Description
Developer of a percutaneous ventricular assist device designed to treat high-risk coronary interventions and cardiogenic shock. The company's device provides temporary mechanical support for severe coronary artery disease or comorbidities to treat patients suffering from cardiogenic shock, enabling patients to recover from heart problems.
Contact Information
Website
www.supiramedical.comCorporate Office
- 130 Knowles Drive
- Suite E
- Los Gatos, CA 95032
- United States
Corporate Office
- 130 Knowles Drive
- Suite E
- Los Gatos, CA 95032
- United States
Supira Medical Timeline
Supira Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Later Stage VC (Series E) | 25-Mar-2025 | $120M | Completed | Clinical Trials - General | ||
| 5. Later Stage VC (Series D) | 21-Nov-2023 | Completed | Clinical Trials - General | |||
| 4. Later Stage VC (Series C) | 25-Feb-2022 | Completed | Clinical Trials - General | |||
| 3. Later Stage VC (Series B) | 25-Feb-2020 | Completed | Pre-Clinical Trials | |||
| 2. Later Stage VC (Series A1) | 25-Apr-2018 | $15.5M | $16M | Completed | Pre-Clinical Trials | |
| 1. Early Stage VC (Series A) | 08-Jun-2012 | $495K | $495K | Completed | Startup |
Supira Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E | ||||||||
| Series D | ||||||||
| Series C | ||||||||
| Series B | ||||||||
| Series A1 | 35,227,261 | $0.000100 | 8% | $0.44 | $0.44 | 1x | $0.44 | 10.7% |
| Series A | 2,750,000 | $0.000100 | 8% | $0.18 | $0.18 | 1x | $0.18 | 0.84% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Supira Medical Comparisons
Industry
Financing
Details
Supira Medical Competitors (4)
One of Supira Medical’s 4 competitors is Magenta Medical, a Venture Capital-Backed company based in Kadima, Israel.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Magenta Medical | Venture Capital-Backed | Kadima, Israel | ||||
| Abiomed | Corporate Backed or Acquired | Danvers, MA | ||||
| JenaValve Technology | Private Equity-Backed | Irvine, CA | ||||
| Cardiac Dimensions | Venture Capital-Backed | Kirkland, WA |
Supira Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Supira Medical Patents
Supira Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4832947-A1 | Sheathing and delivery system for collapsible blood pumps | Pending | 29-Dec-2023 | ||
| EP-4761799-A1 | Catheter blood pumps and associated methods | Pending | 18-Aug-2023 | ||
| EP-4704961-A2 | Catheter blood pumps and associated methods | Pending | 28-Apr-2023 | ||
| US-20260295234-A1 | Catheter blood pumps and associated methods | Pending | 28-Apr-2023 | ||
| EP-4704960-A1 | Catheter blood pumps and associated methods | Pending | 25-Apr-2023 | A61M60/867 |
Supira Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Supira Medical Investors (10)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Novo Holdings | Venture Capital | Minority | ||
| Qatar Investment Authority | Sovereign Wealth Fund | Minority | ||
| Unorthodox Ventures | Venture Capital | Minority | ||
| PA MedTech VC Fund | Corporate Venture Capital | Minority | ||
| Techlink Ventures | Venture Capital | Minority |
Supira Medical FAQs
-
When was Supira Medical founded?
Supira Medical was founded in 2012.
-
Where is Supira Medical headquartered?
Supira Medical is headquartered in Los Gatos, CA.
-
What is the size of Supira Medical?
Supira Medical has 125 total employees.
-
What industry is Supira Medical in?
Supira Medical’s primary industry is Therapeutic Devices.
-
Is Supira Medical a private or public company?
Supira Medical is a Private company.
-
What is the current valuation of Supira Medical?
The current valuation of Supira Medical is .
-
What is Supira Medical’s current revenue?
The current revenue for Supira Medical is .
-
How much funding has Supira Medical raised over time?
Supira Medical has raised $241M.
-
Who are Supira Medical’s investors?
Novo Holdings, Qatar Investment Authority, Unorthodox Ventures, PA MedTech VC Fund, and Techlink Ventures are 5 of 10 investors who have invested in Supira Medical.
-
Who are Supira Medical’s competitors?
Magenta Medical, Abiomed, JenaValve Technology, and Cardiac Dimensions are competitors of Supira Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
